Epilepsy and the new cytogenetics
- PMID: 21269290
- PMCID: PMC3079368
- DOI: 10.1111/j.1528-1167.2010.02932.x
Epilepsy and the new cytogenetics
Abstract
We set out to review the extent to which molecular karyotyping has overtaken conventional cytogenetics in applications related to epilepsy. Multiplex ligase-dependent probe amplification (MLPA) targeted to predetermined regions such as SCN1A and KCNQ2 has been effectively applied over the last half a decade, and oligonucleotide array comparative genome hybridization (array CGH) is now well established for genome-wide exploration of microchromosomal variation. Array CGH is applicable to the characterization of lesions present in both sporadic and familial epilepsy, especially where clinical features of affected cases depart from established syndromes. Copy number variants (CNVs) associated with epilepsy and a range of other syndromes and conditions can be recurrent due to nonallelic homologous recombination in regions of segmental duplication. The most common of the recurrent microdeletions associated with generalized epilepsy are typically seen at a frequency of ∼ 1% at 15q13.3, 16p13.11, and 15q11.2, sites that also confer susceptibility for intellectual disability, autism, and schizophrenia. Incomplete penetrance and variable expressivity confound the established rules of cytogenetics for determining the pathogenicity for novel CNVs; however, as knowledge is gained for each of the recurrent CNVs, this is translated to genetic counseling. CNVs play a significant role in the susceptibility profile for epilepsies, with complex genetics and their comorbidities both from the "hotspots" defined by segmental duplication and elsewhere in the genome where their location and size are often novel.
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.
Conflict of interest statement
Disclosure: Neither author has a conflict of interest to disclose. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3079368/bin/nihms252252f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3079368/bin/nihms252252f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3079368/bin/nihms252252f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3079368/bin/nihms252252f4.gif)
Similar articles
-
Iterative phenotyping of 15q11.2, 15q13.3 and 16p13.11 microdeletion carriers in pediatric epilepsies.Epilepsy Res. 2014 Jan;108(1):109-16. doi: 10.1016/j.eplepsyres.2013.10.001. Epub 2013 Oct 26. Epilepsy Res. 2014. PMID: 24246141
-
Copy number variants are frequent in genetic generalized epilepsy with intellectual disability.Neurology. 2013 Oct 22;81(17):1507-14. doi: 10.1212/WNL.0b013e3182a95829. Epub 2013 Sep 25. Neurology. 2013. PMID: 24068782 Free PMC article. Review.
-
High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy.BMC Med Genet. 2011 Nov 25;12:154. doi: 10.1186/1471-2350-12-154. BMC Med Genet. 2011. PMID: 22118685 Free PMC article.
-
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.Brain. 2010 Jan;133(Pt 1):23-32. doi: 10.1093/brain/awp262. Epub 2009 Oct 20. Brain. 2010. PMID: 19843651 Free PMC article.
-
Channelopathies as a genetic cause of epilepsy.Curr Opin Neurol. 2003 Apr;16(2):171-6. doi: 10.1097/01.wco.0000063767.15877.c7. Curr Opin Neurol. 2003. PMID: 12644745 Review.
Cited by
-
Neuroinflammatory Dysfunction of the Blood-Brain Barrier and Basement Membrane Dysplasia Play a Role in the Development of Drug-Resistant Epilepsy.Int J Mol Sci. 2023 Aug 11;24(16):12689. doi: 10.3390/ijms241612689. Int J Mol Sci. 2023. PMID: 37628870 Free PMC article.
-
Cytogenomic epileptology.Mol Cytogenet. 2023 Jan 5;16(1):1. doi: 10.1186/s13039-022-00634-w. Mol Cytogenet. 2023. PMID: 36600272 Free PMC article. Review.
-
Rare gene deletions in genetic generalized and Rolandic epilepsies.PLoS One. 2018 Aug 27;13(8):e0202022. doi: 10.1371/journal.pone.0202022. eCollection 2018. PLoS One. 2018. PMID: 30148849 Free PMC article.
-
GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant.Neurobiol Dis. 2017 Oct;106:181-190. doi: 10.1016/j.nbd.2017.07.006. Epub 2017 Jul 6. Neurobiol Dis. 2017. PMID: 28688853 Free PMC article.
-
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.Mol Diagn Ther. 2017 Aug;21(4):357-373. doi: 10.1007/s40291-017-0257-0. Mol Diagn Ther. 2017. PMID: 28197949 Review.
References
-
- Auvin S, Holder-Espinasse M, Lamblin MD, Andrieux J. Array-CGH detection of a de novo 0.7-Mb deletion in 19p13.13 including CACNA1A associated with mental retardation and epilepsy with infantile spasms. Epilepsia. 2009;50:2501–2503. - PubMed
-
- Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, Adams MD, Myers EW, Li PW, Eichler EE. Recent segmental duplications in the human genome. Science. 2002;297:1003–1007. - PubMed
-
- Battaglia A, Guerrini R. Chromosomal disorders associated with epilepsy. Epileptic Disord. 2005;7:181–192. - PubMed
-
- Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–685. - PubMed